2015
DOI: 10.1038/ejhg.2015.240
|View full text |Cite
|
Sign up to set email alerts
|

SPG7 mutations explain a significant proportion of French Canadian spastic ataxia cases

Abstract: Hereditary cerebellar ataxias and hereditary spastic paraplegias are clinically and genetically heterogeneous and often overlapping neurological disorders. Mutations in SPG7 cause the autosomal recessive spastic paraplegia type 7 (SPG7), but recent studies indicate that they are also one of the most common causes of recessive cerebellar ataxia. In Quebec, a significant number of patients affected with cerebellar ataxia and spasticity remain without a molecular diagnosis. We performed wholeexome sequencing in t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
31
4

Year Published

2017
2017
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 48 publications
(36 citation statements)
references
References 26 publications
1
31
4
Order By: Relevance
“…Overall, the frequency of SPG7-related cerebellar ataxias in our cohort was lower when compared with previously reported surveys from other populations, ranging from 18.6% in British patients to 19.3% in French-Canadian cases [13,19]. This frequency may indicate a lower prevalence of the variant in patients of Italian ancestry with SPG7.…”
Section: Discussioncontrasting
confidence: 75%
See 1 more Smart Citation
“…Overall, the frequency of SPG7-related cerebellar ataxias in our cohort was lower when compared with previously reported surveys from other populations, ranging from 18.6% in British patients to 19.3% in French-Canadian cases [13,19]. This frequency may indicate a lower prevalence of the variant in patients of Italian ancestry with SPG7.…”
Section: Discussioncontrasting
confidence: 75%
“…This difference was maintained when comparing age at onset of our homozygous individuals with that of classical patients with SPG7 from the literature who were negative for the p.Ala510Val allele [age at onset (mean AE SD), 50.6 AE 7.40 vs. 34.8 AE 12.8 years; P = 0.0004] [12][13][14][17][18][19][20][21][22].…”
Section: Clinical Features Of Spg7-related Ataxia Casesmentioning
confidence: 64%
“…Meta‐analysis combining these data with other cohorts of SPG7 patients can be expected to yield further genotype‐phenotype correlations. Ataxia was present in 65% of the patients as expected, given that pathogenic variants in SPG7 are one of the most common causes of recessive adult‐onset undiagnosed cerebellar ataxia . SPG7 s creening has been proposed in the differential diagnosis of spastic ataxia.…”
Section: Discussionmentioning
confidence: 67%
“…No clear phenotype/genotype correlation has been reported, and these pathogenic variants may result in both pure (lower limb pyramidal weakness with spasticity) or complicated hereditary spastic paraplegia (HSP) phenotypes, with the presence of additional features such as ataxia, intellectual disability, optic atrophy, deafness, dementia, peripheral neuropathy, and epilepsy. 6 Recent studies indicate that SPG7 pathogenic variants are one of the most common causes of recessive adultonset undiagnosed cerebellar ataxia, 7,8 and SPG7 patients may show a wide variety of signs and symptoms, including spastic paraparesis, progressive external ophthalmoplegia (PEO), and optical neuropathy. 1,4,9,10 The clinical spectrum of SPG7 disease continues to expand, and recently levodopa-responsive parkinsonism has been described in 2 patients.…”
mentioning
confidence: 99%
“…SPG7 , identified as a cause of HSP in 1998, 7 was not systematically considered a cause of predominant (and even pure) cerebellar ataxia until 15 years later. 8 Yet, within the past 2 years, it has been appreciated as one of the most common causes of autosomal-recessive cerebellar ataxia, 9,10 and the cerebellar features may be even more pronounced than spasticity in some cohorts. 10 Mutations in PNPLA6 were identified as a cause of autosomal-recessive HSP complicated by motor axonal neuropathy in 2008, leading to the designation SPG39.…”
Section: Discovering the Phenotypic And Genetic Spectrum From The Extmentioning
confidence: 99%